DaVita vs Crane Which Outperforms?

DaVita and Crane stocks are two well-known companies in the financial market with distinct characteristics and performance histories. DaVita is a healthcare company that specializes in kidney care services, while Crane is an industrial products manufacturer. Investors often compare and contrast the two stocks based on their financial metrics, market opportunities, and growth prospects. Understanding the strengths and weaknesses of each company can help investors make informed decisions when considering investing in DaVita or Crane stocks.

DaVita or Crane?

When comparing DaVita and Crane, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between DaVita and Crane.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. DaVita has a dividend yield of -%, while Crane has a dividend yield of 0.5%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. DaVita reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Crane reports a 5-year dividend growth of -6.32% year and a payout ratio of 17.26%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with DaVita P/E ratio at 15.45 and Crane's P/E ratio at 35.87. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. DaVita P/B ratio is 33.06 while Crane's P/B ratio is 5.99.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, DaVita has seen a 5-year revenue growth of 1.00%, while Crane's is -0.34%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with DaVita's ROE at 110.29% and Crane's ROE at 18.11%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $151.62 for DaVita and $163.66 for Crane. Over the past year, DaVita's prices ranged from $103.40 to $169.52, with a yearly change of 63.95%. Crane's prices fluctuated between $109.25 and $188.52, with a yearly change of 72.56%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.